Clinical trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 7 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 5 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Amgen | 4 |
| Ege University | 3 |
| Bezmialem Vakif University | 2 |
| Gazi University | 2 |
| Istanbul University - Cerrahpasa | 2 |
| St. Anna Kinderkrebsforschung | 2 |
| AbbVie | 1 |
| Acibadem University | 1 |
| Akdeniz University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 35 |
| Neoplasms | 9 |
| Leukemia | 8 |
| Leukemia, Myeloid, Acute | 8 |
| Lymphoma, Non-Hodgkin | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Multiple Myeloma | 5 |
| Blast Crisis | 4 |
| Burkitt Lymphoma | 4 |
| Hodgkin Disease | 4 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.